William Blair & Company’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.04K | Hold |
20,000
| – | – | ﹤0.01% | 1758 |
|
2025
Q1 | $5.7K | Hold |
20,000
| – | – | ﹤0.01% | 1743 |
|
2024
Q4 | $11.7K | Hold |
20,000
| – | – | ﹤0.01% | 1726 |
|
2024
Q3 | $8.92K | Buy |
20,000
+10,000
| +100% | +$4.46K | ﹤0.01% | 1754 |
|
2024
Q2 | $26.5K | Sell |
10,000
-26,045
| -72% | -$69K | ﹤0.01% | 1665 |
|
2024
Q1 | $98.8K | Hold |
36,045
| – | – | ﹤0.01% | 1507 |
|
2023
Q4 | $87.6K | Hold |
36,045
| – | – | ﹤0.01% | 1521 |
|
2023
Q3 | $72.8K | Hold |
36,045
| – | – | ﹤0.01% | 1545 |
|
2023
Q2 | $106K | Hold |
36,045
| – | – | ﹤0.01% | 1511 |
|
2023
Q1 | $90.1K | Hold |
36,045
| – | – | ﹤0.01% | 1515 |
|
2022
Q4 | $114K | Hold |
36,045
| – | – | ﹤0.01% | 1468 |
|
2022
Q3 | $107K | Hold |
36,045
| – | – | ﹤0.01% | 1499 |
|
2022
Q2 | $110K | Buy |
+36,045
| New | +$110K | ﹤0.01% | 1526 |
|